Literature DB >> 9481962

Epinephrine at doses used in dentistry deteriorates platelet retention rate.

T Ichinohe1, K Fukuda, Y Kaneko.   

Abstract

Epinephrine promotes platelet aggregation through alpha 2 receptor-mediated mechanisms. In this study, the change in the platelet retention rate (PRR) was investigated before and after submucosal epinephrine injection with or without lidocaine in oral surgical patients during isoflurane-nitrous oxide anesthesia. Thirty-nine consenting patients participated in this study. Subjects were allocated in one of five groups depending on the solution injected, the diclofenac supplement, and the patients' age. PRR was measured immediately before and 5 min after epinephrine injection using a modified form of Saltzman's method. Injection of epinephrine with lidocaine deteriorated PRR, although epinephrine without lidocaine produced no PRR change. Epinephrine at doses used in routine dental practices may activate the platelet aggregating function. Dentists should keep in mind that epinephrine elicits both hemodynamic and platelet-activating effects. The latter may be of clinical importance in some situations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9481962      PMCID: PMC2148836     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  24 in total

1.  MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.

Authors:  E W SALZMAN
Journal:  J Lab Clin Med       Date:  1963-11

2.  Acceleration of epinephrine absorption by lidocaine.

Authors:  W Ueda; M Hirakawa; K Mori
Journal:  Anesthesiology       Date:  1985-12       Impact factor: 7.892

3.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

4.  Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.

Authors:  J I Haft; K Gershengorn; P D Kranz; R Oestreicher
Journal:  Am J Cardiol       Date:  1972-12       Impact factor: 2.778

5.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.

Authors:  B T Mellion; L J Ignarro; E H Ohlstein; E G Pontecorvo; A L Hyman; P J Kadowitz
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

6.  Platelet activation by circulating levels of hormones: a possible link in coronary heart disease.

Authors:  N G Ardlie; H A Cameron; J Garrett
Journal:  Thromb Res       Date:  1984-11-15       Impact factor: 3.944

7.  Potential anti-thrombotic effects of local anaesthetics due to their inhibition of platelet aggregation.

Authors:  T Borg; J Modig
Journal:  Acta Anaesthesiol Scand       Date:  1985-10       Impact factor: 2.105

8.  Standardization of platelet function tests.

Authors:  P R Roper-Drewinko; B Drewinko; G Corrigan; D Johnston; K B McCredie; E J Freireich
Journal:  Am J Hematol       Date:  1981-09       Impact factor: 10.047

9.  Halothane, but not isoflurane or enflurane, protects against spontaneous and epinephrine-exacerbated acute thrombus formation in stenosed dog coronary arteries.

Authors:  B G Bertha; J D Folts; M Nugent; B F Rusy
Journal:  Anesthesiology       Date:  1989-07       Impact factor: 7.892

10.  Inhibition of human platelet functions by verapamil.

Authors:  Y Ikeda; M Kikuchi; K Toyama; K Watanabe; Y Ando
Journal:  Thromb Haemost       Date:  1981-04-30       Impact factor: 5.249

View more
  1 in total

1.  Large-dose epinephrine reduces skeletal muscle blood flow under general anesthesia in rabbits.

Authors:  Yui Terakawa; Tatsuya Ichinohe
Journal:  Anesth Prog       Date:  2012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.